drugset / Trial / NCT00080483
Testosterone and Growth Hormone for Bone Loss in Men
Phase 2
Completed
35 enrolled
University of Pennsylvania
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
Deficiency of testosterone, growth hormone, or both hormones can result in osteoporosis. If either hormone is replaced, the condition of the bones improves. The purpose of this study is to determine if dual hormone treatment for men deficient in testosterone and growth hormone improves bone structure more than testosterone treatment alone.
Timeline
- Start
- 2004-03
- Primary completion
- 2010-09
- Completion
- 2010-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Somatropin | Protein / enzyme biologic | 2 ug/kg | Subcutaneous |
| Comparator | Testosterone | Small molecule | 5 g | Other |